High prevalence of neuropathies in patients with end‐stage liver disease

Dipartimento di Neuroscienze, AOU San Giovanni Battista di Torino, Italy. <>
Acta Neurologica Scandinavica (Impact Factor: 2.4). 11/2009; 122(1):36-40. DOI: 10.1111/j.1600-0404.2009.01256.x
Source: PubMed


Peripheral neuropathy has been reported in association with end-stage liver disease, but there is only a limited number of reports on the incidence and features of these neuropathies.
In this study, 83 patients awaiting liver transplantation were evaluated for the presence of peripheral and autonomic neuropathy.
Sixty-five percent of the patients had evidence of neuropathy, in agreement with peripheral NCS or cardiovascular autonomic function test. The neuropathy was more frequent in patients with advanced hepatic failure, evaluated with the MELD score. The most frequent abnormalities in nerve conduction studies were sensory-motor neuropathies and sensory neuropathies, with a length-dependent pattern.
Peripheral neuropathy and autonomic neuropathy are common in patients with end-stage liver disease with different etiology and correlate with the severity of the liver disease.

1 Follower
20 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The liver plays a central role in energy and nutrient metabolism. Malnutrition is highly prevalent among patients with chronic liver disease and leads to increased morbidity and mortality rates. This review addresses the causes of malnutrition, methods used to assess nutrition status, and appropriate treatment strategies in pediatric patients with chronic liver disease.
    No preview · Article · Apr 2011 · Nutrition in Clinical Practice
  • [Show abstract] [Hide abstract]
    ABSTRACT: Metabolic and endocrine neuropathies, although generally well characterized clinically and electrophysiologically, represent an area in which improved mechanistic understanding is still needed. Although in most cases early detection and reversal of underlying abnormalities is the most effective therapeutic intervention, there are clinical states where metabolic abnormalities may persist for decades without complete resolution, e.g., chronic renal or hepatic failure in the absence of transplantation. In these instances, there remains a compelling clinical impetus for scientific advances in this area. In this chapter, we discuss the clinical manifestations, electrophysiological findings, presumed pathogenesis, treatment options, and prognosis of peripheral neuropathy associated with renal failure, hepatic disease, thyroid dysfunction, and pituitary (acromegaly) dysfunction.
    No preview · Article · Nov 2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose of review: This article summarizes the most common neurologic sequelae of acute and chronic liver failure, liver transplantation, and other treatments for liver disease, and outlines the pathogenesis, neurologic manifestations, and treatment of Wilson disease. Recent findings: The neurologic manifestations of liver disease are caused by the liver's failure to detoxify active compounds that have deleterious effects on the central and peripheral nervous systems. In addition, treatments for liver disease such as liver transplantation, transjugular intrahepatic portosystemic shunt, and antiviral medications can also be neurotoxic. Wilson disease affects the liver and nervous system simultaneously and may often initially be diagnosed by a neurologist; treatment options have evolved over recent years. Summary: Acute and chronic liver diseases are encountered commonly in the general population. Neurologic dysfunction will eventually affect a significant number of these individuals, especially if the disease progresses to liver failure. Early recognition of these neurologic manifestations can lead to more effective management of these patients.
    No preview · Article · Jun 2014 · CONTINUUM Lifelong Learning in Neurology
Show more